The peroxisome: an up-and-coming organelle in immunometabolism

Francesca Di Cara; Stéphane Savary; Werner J. Kovacs; Peter Kim; Richard A. Rachubinski

doi:10.1016/j.tcb.2022.06.001

The peroxisome: an up-and-coming organelle in immunometabolism

Francesca Di Cara, Stéphane Savary, Werner J. Kovacs, Peter Kim, Richard A. Rachubinski

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

54 Citas (Scopus)

Resumen

Peroxisomes are essential metabolic organelles, well known for their roles in the metabolism of complex lipids and reactive ionic species. In the past 10 years, peroxisomes have also been cast as central regulators of immunity. Lipid metabolites of peroxisomes, such as polyunsaturated fatty acids (PUFAs), are precursors for important immune mediators, including leukotrienes (LTs) and resolvins. Peroxisomal redox metabolism modulates cellular immune signaling such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Additionally, peroxisomal β-oxidation and ether lipid synthesis control the development and aspects of the activation of both innate and adaptive immune cells. Finally, peroxisome number and metabolic activity have been linked to inflammatory diseases. These discoveries have opened avenues of investigation aimed at targeting peroxisomes for therapeutic intervention in immune disorders, inflammation, and cancer.

Idioma original	English
Publicación	Trends in Cell Biology
DOI	https://doi.org/10.1016/j.tcb.2022.06.001
Estado	Accepted/In press - 2022

Nota bibliográfica

Funding Information:
This work was supported by Project Grant PJT-169179 from the Canadian Institutes of Health Research (CIHR), Discovery Grant RGPIN/04083-2019 from the Natural Sciences and Engineering Research Council of Canada (NSERC), Research Nova Scotia Establishment Grant MED-EST-2019-2144, and a Dalhousie Medical Research Foundation Start-up grant to F.D.C.; CIHR Foundation Grant FDN-143289 to R.A.R.; NSERC Discovery Grant RGPIN-2020-05865 to P.K.; New Frontiers Research Funds-Exploration grant NFRF-E 19-00007 to S.S. and F.D.C.; the regional council of Bourgogne Franche-Comté and the Ministère de l'Education Nationale et de l'Enseignement Supérieur et de la Recherche (France) to S.S.; Swiss Cancer Research grant KFS-4735-02-2019 and Swiss National Science Foundation grant No. 310030_192614 to W.J.K.

Publisher Copyright:
© 2022 Elsevier Ltd

ASJC Scopus Subject Areas

Cell Biology

PubMed: MeSH publication types

Journal Article
Review

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/j.tcb.2022.06.001

Otros archivos y enlaces

Citar esto

@article{bd3891268899492fb92a555cf79483e0,

title = "The peroxisome: an up-and-coming organelle in immunometabolism",

abstract = "Peroxisomes are essential metabolic organelles, well known for their roles in the metabolism of complex lipids and reactive ionic species. In the past 10 years, peroxisomes have also been cast as central regulators of immunity. Lipid metabolites of peroxisomes, such as polyunsaturated fatty acids (PUFAs), are precursors for important immune mediators, including leukotrienes (LTs) and resolvins. Peroxisomal redox metabolism modulates cellular immune signaling such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Additionally, peroxisomal β-oxidation and ether lipid synthesis control the development and aspects of the activation of both innate and adaptive immune cells. Finally, peroxisome number and metabolic activity have been linked to inflammatory diseases. These discoveries have opened avenues of investigation aimed at targeting peroxisomes for therapeutic intervention in immune disorders, inflammation, and cancer.",

author = "{Di Cara}, Francesca and St{\'e}phane Savary and Kovacs, {Werner J.} and Peter Kim and Rachubinski, {Richard A.}",

note = "Funding Information: This work was supported by Project Grant PJT-169179 from the Canadian Institutes of Health Research (CIHR), Discovery Grant RGPIN/04083-2019 from the Natural Sciences and Engineering Research Council of Canada (NSERC), Research Nova Scotia Establishment Grant MED-EST-2019-2144, and a Dalhousie Medical Research Foundation Start-up grant to F.D.C.; CIHR Foundation Grant FDN-143289 to R.A.R.; NSERC Discovery Grant RGPIN-2020-05865 to P.K.; New Frontiers Research Funds-Exploration grant NFRF-E 19-00007 to S.S. and F.D.C.; the regional council of Bourgogne Franche-Comt{\'e} and the Minist{\`e}re de l'Education Nationale et de l'Enseignement Sup{\'e}rieur et de la Recherche (France) to S.S.; Swiss Cancer Research grant KFS-4735-02-2019 and Swiss National Science Foundation grant No. 310030_192614 to W.J.K. Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",

year = "2022",

doi = "10.1016/j.tcb.2022.06.001",

language = "English",

journal = "Trends in Cell Biology",

issn = "0962-8924",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The peroxisome

T2 - an up-and-coming organelle in immunometabolism

AU - Di Cara, Francesca

AU - Savary, Stéphane

AU - Kovacs, Werner J.

AU - Kim, Peter

AU - Rachubinski, Richard A.

N1 - Funding Information: This work was supported by Project Grant PJT-169179 from the Canadian Institutes of Health Research (CIHR), Discovery Grant RGPIN/04083-2019 from the Natural Sciences and Engineering Research Council of Canada (NSERC), Research Nova Scotia Establishment Grant MED-EST-2019-2144, and a Dalhousie Medical Research Foundation Start-up grant to F.D.C.; CIHR Foundation Grant FDN-143289 to R.A.R.; NSERC Discovery Grant RGPIN-2020-05865 to P.K.; New Frontiers Research Funds-Exploration grant NFRF-E 19-00007 to S.S. and F.D.C.; the regional council of Bourgogne Franche-Comté and the Ministère de l'Education Nationale et de l'Enseignement Supérieur et de la Recherche (France) to S.S.; Swiss Cancer Research grant KFS-4735-02-2019 and Swiss National Science Foundation grant No. 310030_192614 to W.J.K. Publisher Copyright: © 2022 Elsevier Ltd

PY - 2022

Y1 - 2022

N2 - Peroxisomes are essential metabolic organelles, well known for their roles in the metabolism of complex lipids and reactive ionic species. In the past 10 years, peroxisomes have also been cast as central regulators of immunity. Lipid metabolites of peroxisomes, such as polyunsaturated fatty acids (PUFAs), are precursors for important immune mediators, including leukotrienes (LTs) and resolvins. Peroxisomal redox metabolism modulates cellular immune signaling such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Additionally, peroxisomal β-oxidation and ether lipid synthesis control the development and aspects of the activation of both innate and adaptive immune cells. Finally, peroxisome number and metabolic activity have been linked to inflammatory diseases. These discoveries have opened avenues of investigation aimed at targeting peroxisomes for therapeutic intervention in immune disorders, inflammation, and cancer.

AB - Peroxisomes are essential metabolic organelles, well known for their roles in the metabolism of complex lipids and reactive ionic species. In the past 10 years, peroxisomes have also been cast as central regulators of immunity. Lipid metabolites of peroxisomes, such as polyunsaturated fatty acids (PUFAs), are precursors for important immune mediators, including leukotrienes (LTs) and resolvins. Peroxisomal redox metabolism modulates cellular immune signaling such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation. Additionally, peroxisomal β-oxidation and ether lipid synthesis control the development and aspects of the activation of both innate and adaptive immune cells. Finally, peroxisome number and metabolic activity have been linked to inflammatory diseases. These discoveries have opened avenues of investigation aimed at targeting peroxisomes for therapeutic intervention in immune disorders, inflammation, and cancer.

UR - http://www.scopus.com/inward/record.url?scp=85133657270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133657270&partnerID=8YFLogxK

U2 - 10.1016/j.tcb.2022.06.001

DO - 10.1016/j.tcb.2022.06.001

M3 - Review article

C2 - 35788297

AN - SCOPUS:85133657270

SN - 0962-8924

JO - Trends in Cell Biology

JF - Trends in Cell Biology

ER -

The peroxisome: an up-and-coming organelle in immunometabolism

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto